Reports
Sale
Global Clot Management Devices Market Size, Share, Growth: By Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF); By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Clot Management Devices Market Size
The global clot management devices market was valued at USD 1.71 billion in 2023 driven by increasing incidence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 5.12% during the forecast period 2024-2032, reaching a market value of USD 2.59 billion by 2032.
Clot Management Devices Market Outlook
- The market is influenced by the increasing prevalence of cardiovascular diseases, advancements of technology and integration of robotics and artificial intelligence.
- An estimated 17 million deaths occur due to cardiovascular diseases globally, out of which 25% are sudden cardiac deaths (SCD). The application clot management devices to manage the death rate is propelling market growth.
- North America is expected to hold a significant market share of clot management devices due to their high healthcare expenditure, and a high incidence of cardiovascular diseases in the region.
Clot Management Devices Market Overview
Clot management devices are used for the treatment of blood clots to prevent conditions like stroke, deep vein thrombosis, and pulmonary embolism. It offers rapid blood flow restoration and minimal invasive options. Improvements in imaging as well as device flexibility help in improving the efficacy of treatment.
Blood clots are semi-solid clumps of blood. Blood normally flows via arteries and veins without restriction. A certain amount of clotting is required to halt the bleeding if you get hurt or cut. But excessive clotting can result in serious problems. The blood clot forms can be stationary which is known as thrombosis, or it can obstruct blood flow, or it can become loose (known as embolism) and travel to various parts of the body. Clots can obstruct the flow of blood, causing major health concerns like heart attacks and strokes. Clot management devices play a crucial in avoiding such conditions by removing or dissolving clots effectively.
Clot Management Devices Market Growth Drivers
Increasing Incidence of Cardiovascular Diseases (CVDs) Affects the Market Landscape Significantly
The market is driven by the high prevalence of CVDs, technological advancements as well as increasing demand from the aging population and stroke. According to the new Global Burden of Disease (GBD) special report published in December 2023, cardiovascular disease remains a leading cause of death. There is an estimate of 17 million deaths a year globally due to CVDs out of which 25% are sudden cardiac deaths (SCD). Heart attack and stroke account for 85% of cardiovascular deaths.
The rising burden of CVDs significantly influences device adoption and innovation. Due to the rising prevalence of CVDs, more people are susceptible to blood clots which increases the need for clot management devices in both treatment and prevention.
Ease in Government Regulation to meet Rising Global Clot Management Devices Market Demand
Government initiatives and reimbursement policies are driving market growth. Public health campaigns increase demand for early clot detection and treatment, while government funding and grants facilitate innovation. Improved healthcare infrastructure, particularly in developing regions, improves access to quality medical treatments. Favorable reimbursement policies cover advanced procedures, making them more affordable. Financial incentives for healthcare providers and patient assistance programs increase accessibility and adherence to prescribed therapies. These initiatives enhance healthcare standards globally.
Clot Management Devices Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Key Trends | Impact |
| Technological Advancements | Technical advancements have enhanced patient care by facilitating safer removal, accurate identification, and fewer side effects. Artificial intelligence and bioresorbable stents are among new developments. In addition, tools for diagnosis and treatment planning are also using machine learning. |
| Rise in Minimally Invasive Procedures | Minimally invasive procedures are becoming more popular than traditional open surgeries, with procedures such as catheter-directed thrombolysis (CDT) and pharmacomechanical thrombolysis (PMT) garnering popularity. |
| Expanding Applications | These devices are being used in various medical conditions, including cancer-related thrombosis as well as peripheral artery disease . Research and clinical trials are expanding their efficiency, exploring novel applications in oncology and peripheral vascular interventions which enhance patient care and encouraging innovation in medical device technology. |
| Growing Awareness and Screening Programs | An aging world population makes clot-related conditions like venous thromboembolism and atrial fibrillation more common. As people become aware of the risks of blood clots and importance of early diagnosis and treatment, there are more screenings and interventions. |
Clot Management Devices Market Segmentation
Market Breakup by Product
- Neurovascular Embolectomy Devices
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis (CDT) Devices
- Inferior Vena Cava Filters (IVCF)
Market Breakup by End-user
- Hospitals
- Specialty Clinics
- Ambulary Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Clot Management Devices Market Share
Hospitals Segment Based on End-Users Holds a Significant Market Share
End users in the global clot management device market include hospitals, specialized clinics, ambulatory surgery centers (ASCs), and others. Hospitals are poised to hold a significant market share because of their extensive facilities and ability to manage complex operations, ensuring a high rate of use.
Specialty clinics are also poised to hold a notable market share as they offer focused care using specialized equipment and experience. These clinics are specialized in the diagnosis and treatment of conditions associated with blood clotting, deep vein thrombosis (DVT), venous thromboembolism (VTE), and other vascular problems.
Ambulatory surgery centers also use clot management devices and play a crucial role in the market because they make minimally invasive operations like thrombectomy and angioplasty affordable. With the use of cutting-edge medical technology, they can offer same-day surgery with shorter recovery periods and a lower risk of infection, improving patient outcomes and increasing the effectiveness and accessibility of clot management therapies.
Other end users, particularly diagnostic centers, make substantial contributions by providing critical diagnostic and minor treatment choices, thereby assisting the significant healthcare ecosystem in treating clot-related illnesses.
Clot Management Devices Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America along with the Middle East and Africa.
North America holds the largest market share due to its high healthcare spending, an aging population, and a high incidence of cardiovascular disorders such as heart attacks and strokes. The region benefits from considerable technological breakthroughs and substantial investment from major industry participants.
Europe also have a significant market share with major players including Germany, UK, France, and Italy. Rising cardiovascular disease rates, a well-established healthcare system, and a high demand for minimally invasive procedures are driving the region’s market rise.
The Asia Pacific region is experiencing the fastest growth in market due to surge in healthcare investments, improved infrastructure, and rising heart disease rates in countries like China, Japan, and India. This trend is also driven by increased patient numbers in emerging economies.
Leading Players in the Global Clot Management Devices Market
The key features of the market report include patent analysis, as well as strategic initiatives including recent partnerships and collaborations by the leading players. The major companies in the market are as follows:
iVascular
iVascular is a fast-growing company established in 2010 in Barcelona, Spain. It is well-known for its innovations in vascular devices, which include clot management systems such as mechanical thrombectomy devices, thrombolysis systems, and thrombectomy catheters, which are used in cardiovascular and vascular diseases. These devices help to dissolve and remove clots, which improves patient outcomes for diseases like deep vein thrombosis, heart attacks, and strokes.
Boston Scientific Corporation
It is a is a biomedical/biotechnology engineering firm which was established in Delaware in 1979 and has its headquarters in Watertown, Massachusetts. It is known for its large range of medical equipment. It is a key player in the clot management market, particularly in thrombectomy and embolization devices.
Medtronic
Medtronic was established in 1949. It is a key player in the medical device sector, offering a range of clot management devices and actively involved in product development and market expansion.
AngioDynamics
AngioDynamics was founded in 1988 and is headquartered in Latham, New York, USA. It is a medical technology company that focuses on developing, manufacturing, and marketing minimally invasive medical devices for vascular diseases and oncology. They offer clot management devices, including thrombolytic catheters, thrombectomy devices, and venous access devices, used by healthcare professionals to prevent, diagnose, and treat blood clots in various body parts, including veins and arteries.
Other players in the market include BD, Cardinal Health, Cook Medical, Edwards Lifesciences Corporation, Johnson & Johnson Services Inc, LeMaitre Vascular Inc, Stryker, Teleflex Incorporated.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Global Clot Management Devices Market Report
- What was the global clot management devices market value in 2023?
- What is the global clot management devices market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on products?
- Who are the major end users in the market?
- What are the major factors aiding the global clot management devices market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major trends influencing the market?
- What are the major drivers, opportunities, and restraints in the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Which end user will contribute significantly to the market growth?
- Who are the key players involved in the clot management devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clot Management Devices Market Overview
3.1 Global Clot Management Devices Market Historical Value (2017-2023)
3.2 Global Clot Management Devices Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Clot Management Devices Market Landscape*
5.1 Global Clot Management Devices Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Clot Management Devices Market: Product Landscape
5.2.1 Analysis by Product
6 Global Clot Management Devices Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Clot Management Devices Market: Trade Data Analysis (HS Code – 90183990)
7.1 Major Exporting Countries
7.1.1 By Value
7.1.2 By Volume
7.2 Major Importing Countries
7.2.1 By Value
7.2.2 By Volume
8 Global Clot Management Devices Market Segmentation (2017-2032)
8.1 Global Clot Management Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Neurovascular Embolectomy Devices
8.1.3 Embolectomy Balloon Catheters
8.1.4 Percutaneous Thrombectomy Devices
8.1.5 Catheter-Directed Thrombolysis (CDT) Devices
8.1.6 Inferior Vena Cava Filters (IVCF)
8.2 Global Clot Management Devices Market (2017-2032) by End User
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Specialty Clinics
8.2.4 Ambulary Surgical Centers
8.2.5 Others
8.3 Global Clot Management Devices Market (2017-2032) by Region
8.3.1 Market Overview
8.3.2 North America
8.3.3 Europe
8.3.4 Asia Pacific
8.3.5 Latin America
8.3.6 Middle East and Africa
9 North America Clot Management Devices Market (2017-2032)
9.1 Global Clot Management Devices Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Neurovascular Embolectomy Devices
9.1.3 Embolectomy Balloon Catheters
9.1.4 Percutaneous Thrombectomy Devices
9.1.5 Catheter-Directed Thrombolysis (CDT) Devices
9.1.6 Inferior Vena Cava Filters (IVCF)
9.2 Global Clot Management Devices Market (2017-2032) by End User
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Specialty Clinics
9.2.4 Ambulary Surgical Centers
9.2.5 Others
9.3 Global Clot Management Devices Market (2017-2032) by Country
9.3.1 United States of America
9.3.2 Canada
10 Europe Clot Management Devices Market (2017-2032)
10.1 Global Clot Management Devices Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Neurovascular Embolectomy Devices
10.1.3 Embolectomy Balloon Catheters
10.1.4 Percutaneous Thrombectomy Devices
10.1.5 Catheter-Directed Thrombolysis (CDT) Devices
10.1.6 Inferior Vena Cava Filters (IVCF)
10.2 Global Clot Management Devices Market (2017-2032) by End User
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Specialty Clinics
10.2.4 Ambulary Surgical Centers
10.2.5 Others
10.3 Europe Clot Management Devices Market (2017-2032) by Country
10.3.1 United Kingdom
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Others
11 Asia Pacific Clot Management Devices Market (2017-2032)
11.1 Global Clot Management Devices Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Neurovascular Embolectomy Devices
11.1.3 Embolectomy Balloon Catheters
11.1.4 Percutaneous Thrombectomy Devices
11.1.5 Catheter-Directed Thrombolysis (CDT) Devices
11.1.6 Inferior Vena Cava Filters (IVCF)
11.2 Global Clot Management Devices Market (2017-2032) by End User
11.2.1 Market Overview
11.2.2 Hospitals
11.2.3 Specialty Clinics
11.2.4 Ambulary Surgical Centers
11.2.5 Others
11.3 Asia Pacific Clot Management Devices Market (2017-2032) by Country
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 ASEAN
11.3.5 Australia
11.3.6 Others
12 Latin America Clot Management Devices Market (2017-2032)
12.1 Global Clot Management Devices Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Neurovascular Embolectomy Devices
12.1.3 Embolectomy Balloon Catheters
12.1.4 Percutaneous Thrombectomy Devices
12.1.5 Catheter-Directed Thrombolysis (CDT) Devices
12.1.6 Inferior Vena Cava Filters (IVCF)
12.2 Global Clot Management Devices Market (2017-2032) by End User
12.2.1 Market Overview
12.2.2 Hospitals
12.2.3 Specialty Clinics
12.2.4 Ambulary Surgical Centers
12.2.5 Others
12.3 Latin America Clot Management Devices Market (2017-2032) by Country
12.3.1 Brazil
12.3.2 Argentina
12.3.3 Mexico
12.3.4 Others
13 Middle East and Africa Clot Management Devices Market (2017-2032)
13.1 Global Clot Management Devices Market (2017-2032) by Product
13.1.1 Market Overview
13.1.2 Neurovascular Embolectomy Devices
13.1.3 Embolectomy Balloon Catheters
13.1.4 Percutaneous Thrombectomy Devices
13.1.5 Catheter-Directed Thrombolysis (CDT) Devices
13.1.6 Inferior Vena Cava Filters (IVCF)
13.2 Global Clot Management Devices Market (2017-2032) by End User
13.2.1 Market Overview
13.2.2 Hospitals
13.2.3 Specialty Clinics
13.2.4 Ambulary Surgical Centers
13.2.5 Others
13.3 Middle East and Africa Clot Management Devices Market (2017-2032) by Country
13.3.1 Market Overview
13.3.2 Saudi Arabia
13.3.3 United Arab Emirates
13.3.4 Nigeria
13.3.5 South Africa
13.3.6 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 iVascular.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Teleflex Incorporated.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Edwards Lifesciences Corporation.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 LeMaitre Vascular, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 BD
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cook Medical
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Johnson & Johnson Services, Inc .
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Stryker
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Cardinal Health.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 AngioDynamics.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Clot Management Devices Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER